Related Experiment Video

Updated: Aug 8, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

[Recent advances in the clinical use of cytokines]

Fumihiko Kimura

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |May 24, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells
    09:43

    Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells

    Published on: March 8, 2024

    Related Experiment Videos

    Last Updated: Aug 8, 2026

    Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
    11:11

    Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

    Published on: January 24, 2020

    Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells
    09:43

    Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells

    Published on: March 8, 2024

    Related Concept Videos

    Microorganisms in Medicine and Therapeutics01:29

    Microorganisms in Medicine and Therapeutics

    Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Second Transplantation for Relapsed Hematologic Malignancies After First Allogeneic Hematopoietic Stem Cell Transplantation From an HLA-Matched Related Donor.

    Transplantation and cellular therapy·2026

    Development of a stacked ensemble model for risk stratification of chronic GVHD after allogeneic HSCT: Japanese nation-wide cohort study.

    Frontiers in immunology·2026

    Emergent cooperative superstructures via order-disorder kinetics in molecular intercalation superlattices.

    Science advances·2026

    Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

    British journal of haematology·2026

    Prognostic Assessment of Tooth Survival After Treatment of Endodontic-Periodontal Lesions: A Retrospective Study.

    Journal of clinical periodontology·2026

    Measurement Properties of the Japanese Oswestry Disability Index in Preoperative Patients With Lumbar Spinal Stenosis: Effect of Pain and Numbness: A Cross-Sectional Study.

    Health science reports·2026

    [Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Complement-coagulation crosstalk in immunothrombosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    Biologic Switching Strategies for Anti-Tumor Necrosis Factor Alpha Refractory Noninfectious Uveitis:: Systematic Review and Meta-Analysis of Clinical Approach.

    Ophthalmology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us